Skip to content
★ Sign in to follow
IE

Iii Eugene A. Trainor

Iomai CorpGyre Therapeutics, Inc.Paratek Pharmaceuticals, Inc.Vonage Holdings CorpInnerworkings IncInhibitex Inc
Total declarations
29
Companies
6
▲ Purchases (6 ops.)
€18.3M
▼ Sales (4 ops.)
€1,439

Latest filing published 30 Oct 2009 for INHIBITEX INC, €510k.

Insider track record

Disclosed buys
6
Disclosed sells
4
Signal history

No signal scores available.

Closed purchases

Market purchases
6

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Iii Eugene A. Trainor: trading record in brief

Filings by Iii Eugene A. Trainor span 6 companies, the busiest being Innerworkings Inc, Vonage Holdings Corp and Paratek Pharmaceuticals, Inc. We count 29 filings; the first trade dates from 1 February 2006 and the latest from 28 October 2009.

Both buying and selling appear: 6 purchases worth €18.3M, against 4 sales worth €1,439. Taken together, the purchases exceed the sales by €18.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2009, the count stands at 2 purchases and no sales.

Half of the purchases are above €3.2M and half below.

On 30 October 2009 came the latest disclosure, an open-market purchase for €1.5M in Inhibitex Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Iii Eugene A. Trainor

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations23 total

23 of 23 declarations